Abstract: The present invention relates to an LK8-Fc fusion protein, which has increased angiogenesis inhibitory activity and in vivo stability. More specifically, relates to an LK8-Fc fusion protein in which an LK8 protein having angiogenesis inhibitory activity is fused with the Fc region of human immunoglobulin IgG1, as well as a composition for treating cancer, which contains the fusion protein. The LK8-Fc fusion protein has not only angiogenesis inhibitory activity leading to anticancer and metastasis inhibitory activities, but also a very long in vivo half-life, and thus can be used as a more efficient and economic cancer therapeutic agent or cancer inhibitor.

Abstract: The present invention relates to a buckle. More particularly, the present invention is to provide a buckle enabling a belt, which is inserted through an inlet thereof, to be fastened between the upper fastening plate of the body and the elastic movable plate inside the body by installing the fastening plate respectivley in the upper part and the lower part of the buckle and further installing the elastic movable plate, which has an arch shape that the center is convex, inside the buckle body.

Abstract: There is provided a windmill-shaped loop antenna including: a dielectric substrate; a first radiation unit disposed on a top surface of the dielectric substrate and including a metal pattern having loop pieces; a second radiation unit disposed at a bottom surface of the dielectric substrate and including a metal pattern having loop pieces arranged not to face the loop pieces of the first radiation unit; and a plurality of identical transmission line from a center of the top and bottom surfaces of the dielectric substrate to the first and second radiation units, which form windmill-shaped metal pattern with the first and second radiation unit.

Abstract: Embodiments of the present invention may provide a PET-MRI hybrid system capable of arranging a PET apparatus and an MRI apparatus in a line. An MRI room containing the MRI apparatus and a PET room containing the PET apparatus are provided at either side of a central waiting room as opposed to each other about the waiting room. A rail portion linearly extends from the PET room to the waiting room on their bottoms. Another rail portion linearly extends on the bottom of the MRI room. A transfer unit, which supports a subject lying thereon, travels along the rail portions of the waiting room, the MRI room and the PET room. A bridge unit is provided between the rail portion of the waiting room and the rail portion of the MRI room. The bridge unit provides a space for opening and closing a shield door of the MRI room and allows the transfer unit to be reciprocated between the waiting room and the MRI room by selectively connecting the rail portion of the waiting room and the rail portion of the MRI room.

Abstract: The present application discloses a method of reducing tumor growth that includes contacting the tumor with a tumor growth reducing effective amount of a composition comprising LK8 or LK68 protein or a functionally equivalent amino acid variant thereof and a pharmaceutically acceptable carrier thereof to a subject having tumor.

Abstract: There is provided a windmill-shaped loop antenna including: a dielectric substrate; a first radiation unit disposed on a top surface of the dielectric substrate and including a metal pattern having loop pieces; a second radiation unit disposed at a bottom surface of the dielectric substrate and including a metal pattern having loop pieces arranged not to face the loop pieces of the first radiation unit; and a plurality of identical transmission line from a center of the top and bottom surfaces of the dielectric substrate to the first and second radiation units, which form windmill-shaped metal pattern with the first and second radiation unit.

Abstract: A liquid crystal display device includes first and second substrates facing each other, first and second column spacers on the second substrate, a protrusion on the first substrate corresponding to the first column spacer, a compensation pattern on the first substrate corresponding to a periphery of the second column spacer, and a liquid crystal layer between the first and second substrates.

Abstract: The present invention relates to a method of dual Acess Terminal (AT) information of an Overhead Manager (OHM) in an Evolution Data Only (EVDO) control system. The method of the present invention allows both an active OHM and a standby OHM to manage OHM Mobile Terminal (OHMMT) information, such as Radio Link Protocol (RLP) and Signaling Manager (RSM) resource information allocated for each call requested by a terminal, Random Access Terminal ID (RATI) information, Unicast Access Terminal ID (UATI) information allowed when the terminal requests a call, and object addresses connected to a Selector Function (SF) allocated to the terminal that requests a call. Under dualization, terminal call information between the active OHM and the standby OHM coincide and terminal call information is sent from the active OHM to the standby OHM when the standby OHM restarts.

Abstract: A liquid crystal panel and a fabrication method thereof are provided. The liquid crystal panel includes: a gate line and a data line crossing each other to define a pixel; a thin film transistor including: a gate electrode connected to the gate line; a semiconductor layer formed on the gate electrode; a source electrode connected to the data line; a drain electrode; a gate insulating layer between the gate electrode and the drain electrode and between the gate line and the drain electrode; and a compensating parasitic capacitor between the gate line and the drain electrode for compensating a parasitic capacitance between the gate electrode and the drain electrode; and a pixel electrode connected to the drain electrode.

Abstract: The present invention relates to an anticancer or an anti-metastatic agent for gene therapy, more precisely, an anticancer or an anti-metastatic agent for gene therapy containing a gene carrier or cells harboring human apolipoprotein (a) kringle KIV9-KIV10-KV (LK68) or KV (LK8) gene as an effective ingredient, and a treatment method for cancer using the same. The agent for gene therapy of the present invention has an inhibiting effect on the growth and the metastasis of a tumor, so it can be effectively used for the prevention and the treatment of various solid tumors as a metastasis inhibitor or a therapeutic agent for primary tumors.

Abstract: The present invention provide a high dense aluminum nitride sintered body, a preparing method thereof, and a member for manufacturing semiconductor using the sintered body which has excellent leakage current characteristic, enough adsorbing property, good detachment property and excellent thermal conductivity and so can be applied to even a member for manufacturing semiconductor requiring high volume resistivity like the coulomb type electrostatic chucks as well as the Johnsen-Rahbek type electrostatic chucks.

Abstract: The present application discloses a method of reducing tumor growth that includes contacting the tumor with a tumor growth reducing effective amount of a composition comprising LK8 or LK68 protein or a functionally equivalent amino acid variant thereof and a pharmaceutically acceptable carrier thereof to a subject having tumor.

Abstract: The present invention relates to a variant of Lkn-1(shLkn-1) with enhanced biological activity, which is a truncated form of Lkn-1, a process for preparing a recombinant shLkn-1 by employing expression vector therefor and pharmaceutical application of the said protein. shLkn-1 is generated by missing 26 amino acid residues from the amino terminus of Lkn-1 to contain 66 amino acids. Recombinant shLkn-1 inhibits colony formation and cell proliferation in vivo, which suggests that it can be used as a potential drug for the antibody production, the treatment during HIV-1 infection, the protection of bone marrow stem cells during chemotherapy or radiotherapy, and the inhibition of leukemia.

Abstract: A method for forming SBT ferroelectric thin film. Sr(C.sub.5 F.sub.6 HO.sub.2).sub.2, Bi(C.sub.6 H.sub.5).sub.3 and Ta(C.sub.2 H.sub.5 O).sub.5 are used as the precursors of Sr, Bi and Ta and bubbled at a temperature of 110-130.degree. C., 140-160.degree. C., and 120-140.degree. C., respectively. The deposition of the precursors on a substrate is carried out at 500-550.degree. C. in plasma by using an RF power of 100-150 W. Having a residual polarity (Pr) of 15 .mu.C/cm.sup.2 or higher and a coercive electric field (Ec) of 50 kV/cm or less and, the SBT ferroelectric thin film does not show a fatigue phenomenon until 1.times.10.sup.11 cycles as measured under 6V bipolar square pulse in the structure comprising Pt upper and lower electrodes and thus, can be applied for non-volatile memory devices.

Abstract: Improved porous materials useful in blotting analyses of proteinaceous and genomic matter are prepared by treating porous substrates with a gas plasma containing at least one monomer. Thus, a porous sheet-like substrate is modified by means of a deposit of a plasma polymerizate on at least one of its surfaces, whereby this modified surface exhibits reduced nonspecific binding of chemical probes in a blotting analysis. By means of a controlled deposition of the plasma polymer at a plasma composite parameter W/FM of less than 1.0.times.10.sup.9 Joules/kilogram, improved porous materials are obtained having increased signal-to-background ratios and enhanced sensitivities in genomic analyses.